Monopar Therapeutics Statistics
Total Valuation
MNPR has a market cap or net worth of $737.47 million. The enterprise value is $603.37 million.
| Market Cap | 737.47M |
| Enterprise Value | 603.37M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MNPR has 6.71 million shares outstanding. The number of shares has increased by 45.84% in one year.
| Current Share Class | 6.71M |
| Shares Outstanding | 6.71M |
| Shares Change (YoY) | +45.84% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 7.10% |
| Owned by Institutions (%) | 82.83% |
| Float | 4.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 541.37 |
| PB Ratio | 5.68 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 33.56, with a Debt / Equity ratio of 0.00.
| Current Ratio | 33.56 |
| Quick Ratio | 33.44 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.50% and return on invested capital (ROIC) is -15.08%.
| Return on Equity (ROE) | -19.50% |
| Return on Assets (ROA) | -14.64% |
| Return on Invested Capital (ROIC) | -15.08% |
| Return on Capital Employed (ROCE) | -16.89% |
| Weighted Average Cost of Capital (WACC) | 12.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$811,125 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +245.66% in the last 52 weeks. The beta is 1.51, so MNPR's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | +245.66% |
| 50-Day Moving Average | 102.80 |
| 200-Day Moving Average | 73.77 |
| Relative Strength Index (RSI) | 50.29 |
| Average Volume (20 Days) | 257,751 |
Short Selling Information
The latest short interest is 1.07 million, so 15.87% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short Previous Month | 1.36M |
| Short % of Shares Out | 15.87% |
| Short % of Float | 23.79% |
| Short Ratio (days to cover) | 3.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.12M |
| Pretax Income | -17.84M |
| Net Income | -17.84M |
| EBITDA | n/a |
| EBIT | -22.12M |
| Earnings Per Share (EPS) | -$2.18 |
Balance Sheet
The company has $134.30 million in cash and $205,663 in debt, with a net cash position of $134.09 million or $19.98 per share.
| Cash & Cash Equivalents | 134.30M |
| Total Debt | 205,663 |
| Net Cash | 134.09M |
| Net Cash Per Share | $19.98 |
| Equity (Book Value) | 130.85M |
| Book Value Per Share | 19.50 |
| Working Capital | 130.75M |
Cash Flow
| Operating Cash Flow | -12.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -12.18M |
| FCF Per Share | -$1.81 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.84% |
| Shareholder Yield | -45.84% |
| Earnings Yield | -2.40% |
| FCF Yield | -1.64% |
Analyst Forecast
The average price target for MNPR is $126.31, which is 14.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $126.31 |
| Price Target Difference | 14.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 13, 2024. It was a reverse split with a ratio of 1:5.
| Last Split Date | Aug 13, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |